Phosphodiesterase-5-inhibitors compared

被引：0
|
作者：
不详
机构：
来源：
AKTUELLE UROLOGIE | 2005年 / 36卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cardiac Uses of Phosphodiesterase-5 Inhibitors
    Schwartz, Bryan G.
    Levine, Laurence A.
    Comstock, Gary
    Stecher, Vera J.
    Kloner, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (01) : 9 - 15
  • [42] Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction
    Aversa, Antonio
    Bruzziches, Roberto
    Pili, Marcello
    Spera, Giovanni
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (27) : 3467 - 3484
  • [43] Chronic dosing of phosphodiesterase type 5 inhibitors
    Donatucci C.F.
    Current Sexual Health Reports, 2008, 5 (2) : 65 - 69
  • [44] Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
    Tegos, George
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [45] Phosphodiesterase type 5 inhibitors for erectile dysfunction
    Carson, CC
    Lue, TF
    BJU INTERNATIONAL, 2005, 96 (03) : 257 - 280
  • [46] Phosphodiesterase Type 5 Inhibitors: Unmet Needs
    Hatzimouratidis, K.
    Hatzichristou, D. G.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) : 3476 - 3485
  • [47] Phase 4 Studies on Phosphodiesterase 5 Inhibitors
    VanderBeek, Brian L.
    Maguire, Maureen G.
    JAMA OPHTHALMOLOGY, 2022, 140 (05) : 484 - 485
  • [48] The use of phosphodiesterase 5 inhibitors with concomitant medications
    G. Corona
    E. Razzoli
    G. Forti
    M. Maggi
    Journal of Endocrinological Investigation, 2008, 31 : 799 - 808
  • [49] Phosphodiesterase 5 inhibitors: Pharmacology and therapeutic perspectives
    Barbaro, Giuseppe
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (27) : 3437 - 3437
  • [50] Design of second generation phosphodiesterase 5 inhibitors
    Palmer, Michael J.
    Bell, Andrew S.
    Fox, David N. A.
    Brown, David G.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (04) : 405 - 419
12345